Clinical TrialsSearch results
Number of results: 200
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- Establishment of treatments to improve the endometrial microbiome
- infertility
- Mekaru Keiko
- 2022-12-06
Other
- INTEGRAL study
- Diffuse/tandem Coronary Lesions
- Matsuo Hitoshi
- 2020-08-24
Other
- Feasibility study of adjuvant chemotherapy with S-1 in elderly patients with non-small-cell lung cancer
- non-small-cell lung cancer
- Lung Oncology Group in Kyushu, Japan (LOGIK)
- 2009-08-25
Other
- A Phase II Trial of Gefitinib Monotherapy in Elderly Chemo-naïve Patients with Advanced Non–Small Cell Lung Cancer
- Non small cell lung cancer
- LOGIK
- 2005-09-06
Other
- LIVES Study Extention
- hypercholesterolemia
- LIVES Study Extension advisory committee
- 2007-09-18
Other
- Kyushu pitavastatin and pravastatin Intervention trial on Diabetic NEphropathY
- Type 2 diabetic nephropathy with Hypercholesterolemia
- Kyushu University Graduate School of Medical Science Department of Medicine and Bioregulatory Science
- 2008-08-22
Other
- Safety and efficacy of preoperative chemotherapy with mFOLFOX6+Bevacizumab in patients with liver-only metastases (H2, H3) from colorectal cancer; histological assessment of liver damage from preoperative chemotherapy.
- Patients with liver-only metastases from colorectal cancer
- Kyushu Study group of Clinical Cancer
- 2008-08-08
Other
- A Phase I/II Study of Vinorelbine plus Trastuzumab in Patients with Advanced/Recurrent Breast Cancer Previously Treated with Anthracyclines and Taxanes
- Breast cancer
- Kyushu Breast Cancer Study Group
- 2006-07-13
Other
- Capecitabine/cyclophosphamide combination therapy for patients with advanced or metastatic breast cancer who have been previously treated with anthracyclines - a phase 2 study
- Breast cancer
- Kyushu Breast Cancer Study Group
- 2005-07-07
Other
- Feasibility study of adjuvant chemotherapy consisting of FEC(fluoraouracil, epirubicin and cyclophosphamide) followed by DH(docetaxel+herceptin) for patients with HER2 positive breast cancer
- Breast cancer
- Kyushu Breast Cancer Study Group
- 2008-12-17